Motoaki Saito Selected Research

Motoaki Saito Research Topics

Disease

13	Hypertension (High Blood Pressure) 05/2022 - 05/2011
13	Neoplasms (Cancer) 01/2022 - 01/2012
13	Ischemia 07/2021 - 01/2002
11	Body Weight (Weight, Body) 10/2021 - 09/2005
10	Reperfusion Injury 01/2016 - 01/2002
8	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022 - 10/2010
8	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 08/2004
4	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 06/2007
4	Adenocarcinoma 01/2019 - 06/2007
4	Lower Urinary Tract Symptoms 09/2016 - 10/2010
4	Cystitis 09/2016 - 10/2009
4	Renal Cell Carcinoma (Grawitz Tumor) 11/2013 - 01/2012
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2021
3	Nocturia 01/2022 - 08/2005
3	Brain Ischemia (Cerebral Ischemia) 07/2021 - 12/2018
3	Ovarian Epithelial Carcinoma 02/2020 - 09/2014
3	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2019 - 10/2004
3	Carcinoma (Carcinomatosis) 03/2018 - 11/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2017 - 06/2014
3	Clear Cell Adenocarcinoma 12/2012 - 06/2007
3	Type 2 Diabetes Mellitus (MODY) 11/2012 - 08/2010
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2012 - 07/2008
3	Urinary Retention 09/2012 - 09/2009
3	Hypertrophy 02/2006 - 09/2005
2	Venous Thromboembolism 01/2022 - 09/2015
2	Pulmonary Embolism 01/2022 - 09/2015
2	Hyperemia 12/2019 - 01/2019
2	Endometrial Neoplasms (Endometrial Cancer) 06/2019 - 12/2017
2	Urinary Tract Infections (Urinary Tract Infection) 04/2019 - 12/2007
2	Neurogenic Urinary Bladder (Bladder, Neurogenic) 04/2019 - 12/2007
2	Infertility (Sterility) 11/2017 - 01/2016
2	Necrosis 01/2017 - 10/2009
2	Hypoxia (Hypoxemia) 01/2016 - 01/2014
2	Diabetic Nephropathies (Diabetic Nephropathy) 08/2008 - 08/2006
1	Pulmonary Hypertension 02/2022

Drug/Important Bio-Agent (IBA)

7	Interleukin-6 (Interleukin 6)IBA 02/2021 - 10/2013
7	Fatty AlcoholsIBA 01/2019 - 11/2002
6	1-hexacosanolIBA 08/2008 - 01/2006
5	silodosin FDA Link 03/2020 - 07/2012
5	Proteins (Proteins, Gene)FDA Link 12/2017 - 03/2004
5	rho-Associated KinasesIBA 11/2015 - 10/2009
5	EdaravoneIBA 10/2014 - 09/2009
5	Insulin (Novolin)FDA Link 06/2009 - 09/2005
5	Glucose (Dextrose)FDA LinkGeneric 06/2009 - 09/2005
4	Tadalafil (Cialis)FDA Link 01/2022 - 01/2019
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2009
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 06/2007
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 10/2012
4	Cholinergic Antagonists (Anticholinergics)IBA 04/2019 - 08/2004
4	oxybutynin (Tavor)FDA LinkGeneric 04/2019 - 08/2004
4	hydroxyfasudilIBA 11/2015 - 10/2009
4	Nicorandil (SG 75)IBA 01/2015 - 05/2011
4	Free Radical ScavengersIBA 10/2014 - 09/2009
4	Adenosine Triphosphate (ATP)IBA 09/2012 - 06/2010
4	salicylhydroxamic acid (SHAM)IBA 10/2009 - 10/2004
3	Pharmaceutical PreparationsIBA 05/2022 - 08/2005
3	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 06/2019
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2009
3	ZincIBA 07/2021 - 12/2018
3	PlatinumIBA 06/2019 - 07/2007
3	Cisplatin (Platino)FDA LinkGeneric 06/2019 - 07/2007
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2012
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2018 - 06/2006
3	Arginine (L-Arginine)FDA Link 10/2018 - 01/2002
3	Nitric Oxide Synthase (NO Synthase)IBA 10/2018 - 01/2002
3	NG-Nitroarginine Methyl Ester (L-NAME)IBA 05/2011 - 01/2002
2	Losartan (Cozaar)FDA LinkGeneric 05/2022 - 02/2021
2	Peroxidase (Myeloperoxidase)IBA 01/2022 - 10/2009
2	Therapeutic UsesIBA 02/2021 - 01/2019
2	taxaneIBA 06/2019 - 12/2011
2	CytokinesIBA 12/2018 - 01/2016
2	Capsaicin (Zostrix)FDA Link 01/2018 - 09/2016
2	AntioxidantsIBA 11/2017 - 10/2012
2	naftopidilIBA 09/2016 - 04/2013
2	olmesartanIBA 03/2014 - 01/2014
2	Hemoglobins (Hemoglobin)IBA 01/2014 - 10/2013
2	Fas Ligand Protein (Fas Ligand)IBA 10/2013 - 01/2012
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2012 - 07/2007
2	KATP ChannelsIBA 09/2012 - 06/2010
2	PotassiumIBA 09/2012 - 05/2011
2	sivelestatIBA 01/2011 - 04/2008
2	Secretory Proteinase Inhibitory ProteinsIBA 01/2011 - 04/2008
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 10/2010 - 11/2004
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 10/2009 - 03/2004
2	Streptozocin (Streptozotocin)FDA Link 08/2008 - 08/2006
2	loxoprofen (CS 600)IBA 08/2005 - 02/2005
1	levodopa receptorIBA 02/2022
1	MonocrotalineIBA 02/2022
1	ferrous citrate FDA Link 01/2022
1	ImmunosorbentsIBA 01/2022
1	Heme (Haem)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022

Therapy/Procedure

7	Therapeutics 01/2022 - 08/2004
6	Drug Therapy (Chemotherapy) 02/2020 - 08/2005
4	Nephrectomy 11/2013 - 01/2012
4	Surgical Instruments (Clip) 09/2009 - 08/2004
2	Adjuvant Chemotherapy 08/2021 - 06/2019
2	Ischemic Postconditioning 01/2016 - 10/2009
2	Neoadjuvant Therapy 01/2016 - 01/2014
1	Radiotherapy 01/2022